These procedures offer minimally invasive options for many conditions, including early gastrointestinal cancers.
Category: Cancer (Page 4)
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
A groundbreaking clinical trial at UVA Health may shift the approach to treating glioblastoma.
Todd Bauer, MD, leads a laboratory searching for what drives chemo-resistance and metastases in his pancreatic and colorectal cancer patients.
Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
A novel neoadjuvant approach can essentially cure a disease that often gives patients a year or less to live.
UVA Health is among the first 25 centers to bring cancer patients the MRIdian Linac, a significant advance in MR-guided radiation therapy.
Find out what cutting-edge genomics technology uncovered as the critical drivers of gut-related cancers.
UVA Health is testing whether smartwatch-based preconditioning can improve abdominal cancer surgical outcomes.